색전술 시장 조사 - 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00006432
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 255
Buy Now

색전치료제 시장은 2021년 33억 4,149만 달러에서 2028년 57억 5,828만 달러로 성장할 것으로 예상된다. 2022년부터 2028년까지 CAGR 8.1%로 성장할 것으로 예상됩니다.     

색전요법은 혈관 조영 카테터를 사용하여 풍선, 혈전, 코일 또는 겔 폼을 삽입하여 동맥을 폐색시키는 것입니다. 카테터는 출혈성 궤양, 누공 폐쇄 또는 동정맥 기형을 치료하고, 장기의 혈관 제거, 혈관 결함 또는 수술 불가능한 출혈을 제어하기 위해 풍선이나 이물질을 이식하여 혈관을 차단하는 데 도움을 줍니다. 색전요법은 수술 중 종양을 향한 혈류를 멈추는 데에도 사용됩니다.

색전요법 시장은 제품, 질병 적응증, 시술 최종 사용자 및 지역으로 분류됩니다. 지역별로 시장은 북미, 유럽, 아시아 태평양, 중동 및 지역으로 크게 분류됩니다. 아프리카, 남부 & 중앙 아메리카. 이 보고서는 시장 동향, 시장 역학 등의 매개변수에 중점을 두고 시장에 대한 통찰력과 심층 분석, 그리고 전 세계 선두 시장 플레이어의 경쟁 분석을 제공합니다.

전략적 통찰력

< h3>색전요법 시장의 수익성이 높은 지역

시장 통찰력

최소 침습적 시술에 대한 환자 선호도 상승으로 색전요법 시장 증가

수술 후 통증이 적고, 수술 후 합병증이 적고, 입원기간이 짧고, 회복기간이 빨라 최소침습수술을 선호하는 환자가 늘면서 최소침습수술이 늘고 있다. 초기 유방암 환자를 위한 수술의 대안으로 비침습적 또는 최소 침습적 치료법이 개발되고 있습니다.  예를 들어, TACE라고도 알려진 경동맥 화학색전술은 간세포암종 치료에 일반적으로 사용되는 최소 침습적 시술입니다. TACE는 무증상이고 절제 불가능한 간암 환자를 위한 것입니다. TACE는 종양의 크기를 줄이고 환자가 간 이식을 받을 수 있도록 하는 데 사용될 수 있습니다. 이는 경카테터 동맥 색전술(TAE)이라고 불리는 이전 기술의 발전으로 간주됩니다.

전립선 동맥 색전술(PAE)은 또한 하부 요로 증상에 대한 선택적인 외래 환자 기술로 시행되는 최소 침습적 치료법입니다. (LUTS) 양성 전립선 비대증(BPH)에 이차적입니다. 최근 몇 년 동안 PAE로 치료받은 환자의 수가 증가했습니다. 따라서 최소 침습 시술에 대한 선호도가 높아짐에 따라 색전 요법 시장 성장이 가속화되고 있습니다.

제품 정보

제품을 기준으로 색전 요법 시장은 색전 요법제와 지원 장치로 양분됩니다. 색전제는 미세구, 액체 색전제, 색전 코일, 색전 플러그 시스템, 분리형 풍선 등으로 더 세분화됩니다. 지지 장치는 마이크로카테터와 가이드와이어로 더 세분화됩니다. 색전제 부문은 2021년에 가장 큰 시장 점유율을 차지합니다. 또한 동일한 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다. 색전제 부문 성장의 주요 원동력은 다양한 중재 방사선학 절차에서 색전제 사용 증가와 색전제의 발전입니다.

제품별 색전요법 시장 – 2022년 및 2028년

질병 적응증 통찰력

질병 적응증을 기준으로 색전요법 시장은 암, 말초 혈관 질환, 신경계 질환, 비뇨기과 및 신장 질환으로 분류됩니다. 장애, 위장 장애 등. 암은 다시 간암, 신장암 등으로 세분화됩니다. 암 부문은 2021년에 가장 큰 시장 점유율을 차지할 가능성이 높습니다. 또한 동일한 부문은 2022년부터 2028년까지 가장 빠른 CAGR을 기록할 것으로 예상됩니다. 암 부문 성장의 주요 추진 요인은 전 세계적으로 암 발병률이 증가하고 있다는 것입니다.

질병 적응증 통찰력

질병 적응증에 따라 색전요법 시장은 경피적 동맥 색전술(TAE), 경피적 동맥 방사선 색전술(TARE)/선택적 내부 방사선 요법(SIRT), 및 경동맥 화학색전술(TACE). 경피적 동맥색전술(TAE) 부문은 2021년 가장 큰 시장 점유율을 차지합니다. 또한, 동일한 부문은 2022~2028년 동안 가장 빠른 CAGR을 기록할 것으로 예상됩니다. 경피 동맥 색전술(TAE) 부문의 성장을 이끄는 주요 요인은 노인의 최소 침습적 시술에 대한 선호도 증가, 만성 질환 유병률 증가, 노인 인구의 급속한 증가입니다.

최종 사용자 통찰력

최종 사용자를 기준으로 색전요법 시장은 병원 및 의료 시장으로 분류됩니다. 진료소, 외래 수술 센터 및 기타 최종 사용자. 2021년에는 병원 & 클리닉 부문은 시장에서 가장 큰 점유율을 차지할 가능성이 높습니다. 또한, 동일한 부문은 2022년부터 2028년까지 가장 높은 CAGR을 기록할 것으로 예상됩니다. 병원 & 클리닉 부문에는 최소 침습적 수술 절차(혈관, 비뇨기과 및 신경학 포함)의 채택 증가, 암과 같은 다양한 질병 치료를 위한 병원 내 환자 증가, 이러한 시설에서 수행되는 색전술 절차의 증가, 대형 병원, 소규모 진료소, 중환자실에서 복잡한 시술을 정밀하게 수행할 수 있는 최첨단 색전요법 장치입니다.

제품 출시 및 승인과 같은 유기적 개발은 색전요법 시장의 기업들이 많이 채택하는 전략입니다. . 최근 주요 시장 발전 중 몇 가지가 아래에 나열되어 있습니다.

  • 2022년 4월 Boston Scientific Corporation은 510(k ) 말초 혈관계의 혈류를 방해하거나 감소시키기 위한 EMBOLD 섬유 분리형 코일에 대한 미국 식품의약국(FDA)의 허가를 받았습니다. Boston Scientific의 중재적 종양학 포트폴리오에 가장 최근 추가된 EMbol Fibered Coil은 하나 이상의 혈관을 차단하여 혈류를 방해하거나 감소시키는 최소 침습 치료법인 다양한 색전술 절차에 사용하도록 설계되었습니다.
  • 2021년 9월 Abbott는 말초 혈전을 제거하도록 설계된 최소 침습 기계적 흡인 혈전 제거 시스템을 갖춘 상용 단계 의료 기기 회사인 Walk Vascular, LLC를 인수했다고 발표했습니다. Walk Vascular의 말초 혈전 제거 시스템은 Abbott의 기존 혈관내 제품 포트폴리오에 통합될 예정입니다.

회사 프로필

  • Abbott
  • Boston Scientific Corporation< /li>
  • Cook Medical LLC
  • Johnson & Johnson
  • Medtronic
  • Acandis GmbH
  • SSEM Mthembu Medical (Pty) Ltd
  • Balt USA LLC
  • Stryker
  • 게르베 LLC
  • 테루모 코퍼레이션
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is embolotherapy?

Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils or gel foam using an angiographic catheter. The catheter aids to block a blood vessel by implanting balloon or any foreign body, in order to treat bleeding ulcer, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defect or for control of inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery.

What are the driving factors for the global embolotherapy market worldwide?

The factors driving the growth of the embolotherapy market are rising incidence of cancer cases, rising patient preference for minimally invasive procedures, and increasing incidence of hypertension, obesity, smoking, and alcoholism.

What are the restraining factors for the global embolotherapy market worldwide?

The availability of other alternative therapies, and the high cost of embolotherapy are expected to restrict the embolotherapy market growth during the forecast period.

Who are the major players in the embolotherapy market across the globe?

The embolotherapy market majorly consists of the players, such as as Abbott Laboratories, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson Consumer Inc., Medtronic, Acandis GmbH, Terumo Corporation, Balt USA LLC, Stryker Corporation, and Guerbet LLC, among others.

Which segment is dominating the embolotherapy market?

The global embolotherapy market based on product is bifurcated into embolic agents and support devices. The embolic agents is further sub-segmented into microsphere, liquid embolics agents, embolic coils, embolic plug systems, detachable balloons, and others. The support devices is further sub-segmented into microcatheters, and guidewires. The embolic agents segment is likely to hold the largest market share in 2021. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period

Which region is dominating the embolotherapy market?

The global embolotherapy market based on regions is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In 2021, the North American area held the largest market share. However, the Asia Pacific region is estimated to grow at the fastest CAGR of 8.5% during the forecast period

The List of Companies - Embolotherapy Market

  1. Abbott Laboratories           
  2. Boston Scientific Corporation         
  3. Cook Medical LLC                
  4. Johnson & Johnson Consumer Inc                
  5. Medtronic              
  6. Acandis GmbH     
  7. Terumo Corporation          
  8. Balt USA LLC          
  9. Stryker Corporation           
  10. Guerbet LLC.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports